Get Your Personalized Supplement StackSupplement Stack Quiz

Japanese Honeysuckle

Also known as: Japanese honeysuckle, Chinese honeysuckle, honeysuckle, Lonicera japonica

Overview

Japanese honeysuckle (*Lonicera japonica*) is a perennial vine native to East Asia, commonly utilized in traditional Chinese medicine for its assorted health benefits. Known for containing bioactive compounds such as flavonoids, saponins, and iridoid glycosides, this plant has been traditionally used to alleviate conditions like fever, cough, and inflammatory diseases. Recent research has highlighted its potential role in treating viral infections, including COVID-19. While research is expanding, especially in the context of its medicinal applications, the overall quality of existing studies can vary, necessitating further investigation into its efficacy and safety.

Benefits

Several evidence-based benefits of Japanese honeysuckle have been reported, particularly in the context of COVID-19 treatment. A systematic review and meta-analysis showed that when combined with conventional treatments, it significantly improved lung computed tomography outcomes (Relative Risk (RR) = 1.24), clinical cure rates (RR = 1.21), and reduced the conversion rate to severe cases (RR = 0.50). Secondary benefits included notable improvements in fever and cough symptoms, with significant reductions in inflammatory biomarkers like white blood cell count and C-reactive protein. Primarily, these benefits have been observed in adult patients diagnosed with COVID-19.

How it works

The mechanisms through which Japanese honeysuckle operates are not completely understood; however, its bioactive compounds are believed to exhibit anti-inflammatory, antiviral, and immunomodulatory effects. These interactions mainly influence the immune system by reducing inflammatory markers and improving clinical symptoms. Despite some insights into its potential mechanisms, specific molecular targets remain largely undefined in the literature.

Side effects

The safety profile of Japanese honeysuckle appears favorable based on available evidence, particularly in the setting of COVID-19 treatment. Common side effects are not extensively documented, and there are no known significant common (greater than 5%), uncommon (1% to 5%), or rare (less than 1%) side effects linked with its supplementation in the current literature. Data on drug interactions are also limited, suggesting a lack of comprehensive investigation in this area. There are no established contraindications, but caution is warranted in populations outside the studied adult demographic with COVID-19 due to insufficient data.

Dosage

In clinical studies focusing on Japanese honeysuckle, dosages typically ranged from 5 to 30 grams per day, effective within this spectrum for treating COVID-19. While the minimum effective dose is known, the optimal dosage is still unclear. The duration of treatment applied in studies was between 5 to 15 days, tailored to the specific therapeutic outcomes being measured. Unfortunately, detailed information regarding absorption factors and required cofactors is limited, complicating the establishment of standardized dosing practices.

FAQs

How is Japanese honeysuckle used in COVID-19 treatment?

Japanese honeysuckle is used in combination with conventional treatments to enhance clinical outcomes for COVID-19, showing significant improvements in lung CT outcomes and symptom relief.

What are the safety concerns related to Japanese honeysuckle?

Current evidence indicates Japanese honeysuckle is safe when used as part of combination therapy for COVID-19, but more comprehensive studies are needed to assess other uses and population safety.

What is the recommended dosing of Japanese honeysuckle?

Dosages from clinical studies range from 5 to 30 grams per day for 5 to 15 days, but optimal dosing remains undetermined.

What improvements can I expect from using Japanese honeysuckle?

Notable improvements such as enhanced lung function, clinical recovery rates, and reduction in symptoms like fever and cough have been observed.

Is Japanese honeysuckle safe for everyone?

Although generally safe in adults with COVID-19, there is limited data on its safety for other age groups and conditions, warranting caution.

Research Sources

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.708636/full – A systematic review and meta-analysis of nine randomized controlled trials involving 1,286 adult patients with COVID-19 showed that Japanese honeysuckle combined with conventional therapy leads to significant improvements in lung CT outcomes and clinical recovery rates.
https://pubmed.ncbi.nlm.nih.gov/39203859/ – Research findings on various applications of Japanese honeysuckle highlight its potential health benefits; however, implications beyond COVID-19 treatment require further investigation.